pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer.
Ray P, Dutta D, Haque I, Nair G, Mohammed J, Parmer M, Kale N, Orr M, Jain P, Banerjee S, Reindl KM, Mallik S, Kambhampati S, Banerjee SK, Quadir M.
Ray P, et al. Among authors: reindl km.
Mol Pharm. 2021 Jan 4;18(1):87-100. doi: 10.1021/acs.molpharmaceut.0c00499. Epub 2020 Nov 24.
Mol Pharm. 2021.
PMID: 33231464